Advertisement
Mayo Clinic Proceedings Home

Angiotensin-Converting Enzyme Inhibitors and Obstructive Sleep Apnea

      Angiotensin-converting enzyme (ACE) inhibitors may induce cough and rhinopharyngeal inflammation. Obstructive sleep apnea (OSA) is characterized by upper airway inflammation. We describe a patient who, during enalapril treatment, developed cough, upper airway symptoms, and diurnal sleepiness, with an increased number of obstructive apnea-hypopnea episodes (apnea-hypopnea index [AHI], 25) during sleep. Her symptoms and AHI improved 1 month after enalapril was discontinued and diuretic therapy (hydrochlorothiazide-spironolactone) was initiated. Similar findings were observed in 4 other patients with OSA who had ACE inhibitor-induced cough. The mean ± SD AHI was 33.8±21.0 during enalapril treatment and 20.0±17.0 after withdrawal of this drug (P=.04). Exhaled nitric oxide, a marker of airway inflammation, was increased during enalapril treatment (15.0±4.3 parts per billion) and decreased after discontinuation of this drug (9.0±2.6; P=.03). No significant difference in the AHI and exhaled nitric oxide was observed in 4 patients with OSA who did not experience cough, before or after withdrawal of ACE inhibitor treatment. These findings suggest that ACE inhibitor treatment may contribute to OSA by inducing upper airway inflammation.
      ACE (angiotensin-converting enzyme), AHI (apnea-hypopnea index), NO (nitric oxide), OSA (obstructive sleep apnea), ppb (parts per billion)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Linz W
        • Wiemer G
        • Gohlke G
        • Unger T
        • Schölkens BA
        Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
        Pharmacol Rev. 1995; 47: 25-49
        • Sekosan M
        • Zakkar M
        • Wenig BL
        • Olopade CO
        • Rubinstein I
        Inflammation in the uvula mucosa of patients with obstructive sleep apnea.
        Laryngoscope. 1996; 106: 1018-1020
        • Paulsen FP
        • Steven P
        • Tsokos M
        • et al.
        Upper airway epithelial structural changes in obstructive sleep-disordered breathing.
        Am J Respir Crit Care Med. 2002; 166: 501-509
        • Deykin A
        • Massaro AF
        • Drazen JM
        • Israel E
        Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate.
        Am J Respir Crit Care Med. 2002; 165: 1597-1601
      1. Rechtschaffen A Kales A A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects. US Dept of Health, Education of Welfare, Bethesda, Md1968 (NIH Publication 204.)
        • Sulpizio AC
        • Pullen MA
        • Edwards RM
        • Brooks DP
        The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
        J Pharmacol Exp Ther. 2004; 309: 1141-1147